Phone Us: 011 304 7851

Netcare Waterfall City Hospital, Corner Magwa Cresent & Mac Mac Av Midrand

Physiotherapy in Midrand at Waterfall Clinic

“Help me, help myself.” - Maria Montessori

How Did We Get Here?

 Jacqui Schewitz (nee Krawitz) and Robert Lelaka decided to open a joint practice at Waterfall City Hospital when it started in July 2011.

What Have We Achieved?

We have been accepted as physiotherapists at Waterfall City hospital and have full practicing privileges. Since our inception, we have grown to have more referring doctors, a network among the Midrand GPs, and an ongoing relationship with local retirement villages. In terms of personnel we have grown, to now a staff of a full time physiotherapist, a part time therapist, and two therapists that assist on weekends.

Our Mission

  • To ensure quality physiotherapy services that are up to date with the latest research, at Netcare Waterfall City Hospital.
  • Provide caring, compassionate physiotherapy care for our patients as well as educate them, so that they may better understand their condition and its management, in order to manage their condition at home.
  • To provide services to the doctors who refer to us by maintaining an open form of communication with them, being on-call, and presenting them with accurate feedback regarding patients.
  • Assist the nursing staff to work in a multidisciplinary environment, and provide education within the context of physiotherapy.
  • Maintain and keep up-to-date with academic research, and continue involvement within the general physiotherapy community through professional development.

Make an Appointment

If you would like to make an appointment, please feel free to contact us:

Or use our contact form. We’ll get back to you as soon as possible! Contact Form



This section of the practice is both in- and out-of-hospital. The in-hospital cases are normally orthopaedic in nature. These patients are followed up from ICU or Surgical Ward to discharge and then as outpatients. Being first line practitioners, we also see patients who walk into our rooms for help with sports injuries or other musculoskeletal complaints.

Respiratory Therapy

This comprises of post-surgical cases such as general surgery, cardio-thoracic, urology, orthopaedics, neurology, maternity etc. We are also involved with medical patients who need physiotherapy services – for example, those with an acute disease such as pneumonia, and those with a chronic disease such as COPD. This therapy is mainly provided within the wards of the hospital but can also be provided on an outpatient setting or at home for patients who require it.


We see children in hospital, usually in a respiratory context. We also see children in our rooms for out-of-hospital respiratory complications.


We see acute stroke patients within the ICU and Medical Wards. These patients can be followed up after discharge to continue their rehabilitation. Patients can be seen at home if they are living in the surrounding area and are unable to travel to the hospital.

The Team


What is physiotherapy?

Physiotherapy is paramedical intervention that aims to decrease pain and improve function. It involves rehabilitation of the body and helps with healing of most medical and surgical conditions. It is appropriate for a range of muscle, joint and nerve conditions whether resulting from injury, illness or disability.
A range of techniques are available for each condition, and your physiotherapist will choose what is appropriate for you and your condition. They can also advise on lifestyle changes that may reduce problems or injuries. The physiotherapist may refer you to another socialist if they feel that it is appropriate.

Is physiotherapy massage?

No. Physiotherapy may use some massage techniques to realise tissues, but it uses other techniques for treatment, and not just relieve the symptoms.

What types of problem can physiotherapy help?

Physiotherapy can help with muscle and joint problems, as well as respiratory and neurological conditions.

What does the treatment involve? / What treatments will you use?

During the first treatment, the physiotherapist will perform a full assessment, and then treat according to what was found in the assessment.

What should I wear?

You can come in the clothes that you would be wearing. We have gowns and shorts, and may request that you change into these, if specific body parts need to be exposed.

How long do sessions last?

Each session lasts approximately 30 minutes, although the first session may be longer, as the primary assessment needs to be performed.

How much will it cost?

We charge medical aid rates. Since each medical aid pays a different amount, we charge according to your medical aid. Private patients are charged the rate of Discovery medical aid. Compensation for accidental injuries will be submitted directly to them. All the necessary documents must be submitted.

Do you get treatment on your initial appointment?

Your first session will involve a full assessment, and in most cases, treatment will occur and recommendations will be made.

Do I need to see my doctor first?

No, we are first-line practitioners.

Will it hurt?

Physiotherapy should not hurt. However, there may be some discomfort. If your treatment is too unpleasant, please feel free to talk to your therapist.

Can I bring someone with me?

Yes, you are welcome to bring someone along. However, due to space constraints, if there are too many people, they may be asked to wait in the waiting room.

Tips & News

Exercise in type 2 diabetes: to resist or to endure?

On Mar 17, 2014


There is now evidence that a single bout of endurance (aerobic) or resistance exercise reduces 24 h post-exercise subcutaneous glucose profiles to the same extent in insulin-resistant humans with or without type 2 diabetes. However, it remains to be determined which group would benefit most from specific exercise protocols, particularly with regard to long-term glycaemic control. Acute aerobic exercise first accelerates translocation of myocellular glucose transporters via AMP-activated protein kinase, calcium release and mitogen-activated protein kinase, but also improves insulin-dependent glucose transport/phosphorylation via distal components of insulin signalling (phosphoinositide-dependent kinase 1, TBC1 domain family, members 1 and 4, Rac1, protein kinase C). Post-exercise effects involve peroxisome-proliferator activated receptor-γ coactivator 1α and lead to ATP synthesis, which may be modulated by variants in genes such as NDUFB6. While mechanisms of acute resistance-type exercise are less clear, chronic resistance training activates the mammalian target of rapamycin/serine kinase 6 pathway, ultimately increasing protein synthesis and muscle mass. Over the long term, adherence to rather than differences in metabolic variables between specific modes of regular exercise might ultimately determine their efficacy. Taken together, studies are now needed to address the variability of individual responses to long-term resistance and endurance training in real life.

Download the Full PDF

Systemic manifestations and comorbidities of COPD.

On Mar 17, 2014


Increasing evidence indicates that chronic obstructive pulmonary disease (COPD) is a complex disease involving more than airflow obstruction. Airflow obstruction has profound effects on cardiac function and gas exchange with systemic consequences. In addition, as COPD results from inflammation and/or alterations in repair mechanisms, the “spill-over” of inflammatory mediators into the circulation may result in important systemic manifestations of the disease, such as skeletal muscle wasting and cachexia. Systemic inflammation may also initiate or worsen comorbid diseases, such as ischaemic heart disease, heart failure, osteoporosis, normocytic anaemia, lung cancer, depression and diabetes. Comorbid diseases potentiate the morbidity of COPD, leading to increased hospitalisations, mortality and healthcare costs. Comorbidities complicate the management of COPD and need to be evaluated carefully. Current therapies for comorbid diseases, such as statins and peroxisome proliferator-activated receptor-agonists, may provide unexpected benefits for COPD patients. Treatment of COPD inflammation may concomitantly treat systemic inflammation and associated comorbidities. However, new broad-spectrum anti-inflammatory treatments, such as phosphodiesterase 4 inhibitors, have significant side-effects so it may be necessary to develop inhaled drugs in the future. Another approach is the reversal of corticosteroid resistance, for example with effective antioxidants. More research is needed on COPD comorbidities and their treatment.

Download the Full PDF

Contact Us